Sort   by:  
 Page size 
UnknownRevealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome.
Not available
S-EPMC8323864 | biostudies-literature
UnknownIntegrative identification of non-coding regulatory regions driving metastatic prostate cancer.
Not available
S-EPMC11466230 | biostudies-literature
UnknownA phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumors.
Not available
S-EPMC8342450 | biostudies-literature
UnknownAAVR-Displaying Interfaces: Serotype-Independent Adeno-Associated Virus Capture and Local Delivery Systems.
Not available
S-EPMC6831863 | biostudies-literature
UnknownExploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein-Protein Interactions with Heat Shock Protein 70 (Hsp70).
Not available
S-EPMC6104643 | biostudies-literature
UnknownOutcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy.
Not available
S-EPMC7050154 | biostudies-literature
UnknownMapping the Genetic Landscape of Human Cells.
Not available
S-EPMC6426455 | biostudies-literature
UnknownGenome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer.
Not available
S-EPMC12695660 | biostudies-literature
UnknownTalazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
Not available
S-EPMC10600918 | biostudies-literature
UnknownTalazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial.
Not available
S-EPMC10649377 | biostudies-literature
Sort   by:  
 Page size